Journal
DIGESTIVE DISEASES AND SCIENCES
Volume 67, Issue 11, Pages 5315-5326Publisher
SPRINGER
DOI: 10.1007/s10620-022-07412-z
Keywords
Cirrhosis; Liver transplantation; Hepatorenal syndrome; Hepatic Encephalopathy; Heart failure; Survival
Categories
Ask authors/readers for more resources
This study found that replacing the World Congress of Gastroenterology criteria with the Cirrhotic Cardiomyopathy Consortium criteria did not significantly affect the diagnosis frequency and clinical outcomes. Patients with advanced diastolic dysfunction according to the Consortium criteria were more likely to experience pre-transplant mortality and complications of acute kidney injury/hepatic encephalopathy. These patients may benefit from further monitoring and treatment.
Background Recently, the Cirrhotic Cardiomyopathy Consortium (Consortium) proposed criteria to replace the World Congress of Gastroenterology (WGO) criteria for cirrhotic cardiomyopathy (CCM) using contemporary echocardiography parameters. We assessed the impact of substituting WGO by Consortium criteria on the frequency of diagnosis and clinical outcomes in patients with cirrhosis awaiting liver transplantation (LT). Methods Consecutive adults with cirrhosis approved for LT with echocardiography evaluation from January 2014 to December 2016 were screened. Patients with structural heart diseases were excluded. Two primary outcomes were: (1) frequency of CCM; (2) association of CCM with pre-transplant mortality. The secondary outcomes were pre-LT complications of acute kidney injury (AKI) and/or hepatic encephalopathy (HE), and post-LT mortality. Results Of 386 patients screened, 278 were included. 238 (85.6%) and 208 (74.8%) patients met Consortium and WGO criteria, respectively; 180 (64.7%) patients fulfilled both the criteria, while 12 (4.3%) patients had no evidence of CCM by either criterion. Pre-LT mortality rates in Consortium-CCM group were similar to the other groups (19.3% vs 20.2% vs 25.0%). The patients with advanced diastolic dysfunction (DD) per Consortium-CCM criteria had higher mortality than the other groups. The rates of pre-LT AKI/HE rates and post-LT mortality were similar in Consortium-CCM and WGO-CCM groups. Conclusion The Consortium criteria do not impact the prevalence of CCM compared to WGO criteria and have similar predictive accuracy. Presence of advanced DD per the Consortium criteria increases the risk of pre-LT mortality and complications of AKI/HE. The patients with advanced DD could benefit from further monitoring and treatment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available